Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 893727
                    [Title] => Screening combo finds HCC in cirrhosis patients
                    [Summary] => 
A combination of ultrasound and alpha-fetoprotein testing identified almost all hepatocellular carcinomas in patients with cirrhosis that was primarily associated with chronic hepatitis C, a retrospective study has shown.

                    [DatePublished] => 2013-01-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 307138
                    [Title] => Leading liver expert to attend Cebu gab
                    [Summary] => One of the world’s top liver transplant experts will discuss with Filipino doctors the benefits of medical treatment in Singapore, Asia’s leading medical destination, particularly for liver disease patients who face difficulties in finding cadaveric livers for transplant, during an upcoming convention in Cebu City this month.


                    [DatePublished] => 2005-11-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

LIVER DISEASE AND TRANSPLANTATION

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 893727
                    [Title] => Screening combo finds HCC in cirrhosis patients
                    [Summary] => 
A combination of ultrasound and alpha-fetoprotein testing identified almost all hepatocellular carcinomas in patients with cirrhosis that was primarily associated with chronic hepatitis C, a retrospective study has shown.

                    [DatePublished] => 2013-01-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 307138
                    [Title] => Leading liver expert to attend Cebu gab
                    [Summary] => One of the world’s top liver transplant experts will discuss with Filipino doctors the benefits of medical treatment in Singapore, Asia’s leading medical destination, particularly for liver disease patients who face difficulties in finding cadaveric livers for transplant, during an upcoming convention in Cebu City this month.


                    [DatePublished] => 2005-11-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Screening combo finds HCC in cirrhosis patients

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 6, 2013 - 12:00am

A combination of ultrasound and alpha-fetoprotein testing identified almost all hepatocellular carcinomas in patients with cirrhosis that was primarily associated with chronic hepatitis C, a retrospective study has...

Opinion

Leading liver expert to attend Cebu gab

November 17, 2005 - 12:00am

One of the world’s top liver transplant experts will discuss with Filipino doctors the benefits of medical treatment in Singapore, Asia’s leading medical destination, particularly for liver disease patients...

Science and Environment